HOME
HIV-HBV Coinfection
Hepatitis C
HIV and AIDS
Hepatitis B
HIV-HCV Coinfection
HIV-HBV Coinfection
Main Section
 Google Custom Search
HIV-HBV Coinfection Top News Articles
SMART Study Shows Antiretroviral Treatment Interruption Is Particularly Risky for Patients with HIV-HBV or HIV-HCV Coinfection - 12/05/2008
Baseline CD4 Cell Count Predicts HBV DNA Decline in HIV Negative and HIV Positive Patients Treated with Adefovir (Hepsera) - 12/05/2008
Management of HIV Positive Patients with Chronic Hepatitis B Who Are Not Eligible for Antiretroviral Therapy - 11/25/2008
Tenofovir (Viread) for Patients with HIV-HBV Coinfection - 11/21/2008
HAART Improves Hepatitis B Vaccine Response Regardless of CD4 Count - 11/07/2008
Liver Enzyme Elevations in HIV Positive Individuals with Occult Hepatitis B Virus Infection - 10/17/08
Thai Study Confirms Efficacy of Tenofovir (Viread) Regimens for HIV-HBV Coinfected Patients - 10/14/08
Laboratory Study Provides Details on Entecavir (Baraclude) Activity against Various Types of HIV - 8/29/08
HIV Positive Individuals Are at Higher Risk of Occult Hepatitis B Virus Infection, but Occult Hepatitis C Virus Is Rare - 8/22/08
Predictors of Hepatitis B Surface Antigen Loss in HIV-HBV Coinfected Individuals - 8/08/08
Updated Recommendations for Management of HIV Positive Patients with Chronic Hepatitis B Virus Coinfection - 7/15/2008
Multicenter Evaluation Sheds Further Light on Anti-HIV Activity of Entecavir (Baraclude) - 6/20/08
Influence of Occult Hepatitis B Virus on Liver Disease Progression and Response to Interferon-based Therapy in HIV-HCV Coinfected Patients - 6/10/08
FDA Proposes New Rule to Provide Updated Information on Use of Prescription Drugs and Biological Products during Pregnancy and Breast-feeding - 5/30/08
Risk of Using Entecavir (Baraclude) without Concomitant Antiretroviral Therapy in HIV-HBV Coinfected Patients - 5/15/08
Hepatitis B Coinfection Does Not Interfere with Response to Antiretroviral Therapy  - 4/15/08
Another Report of Drug-resistant HIV in a Patient Treated with Entecavir (Baraclude) for Hepatitis B  - 4/11/08
Hepatitis Flares in HIV-HBV Coinfected Patients Starting HAART May Be Due to Immune Restoration - 3/04/08
HIV Coinfection Contributes to Mortality Related to Chronic Hepatitis B and C in France - 2/29/08
Hepatitis B Coinfection Does Not Impact HIV Suppression or CD4 Cell Recovery on HAART - 2/26/08
Two Studies Look at Anti-HIV Activity of Entecavir (Baraclude) - 2/12/08
Effect of HAART and Hepatitis B Vaccination on Epidemiology of HIV-HBV Coinfection - 2/05/08
HIV Entry into Hepatic Stellate Cells Promotes Liver Fibrosis Progression - 2/05/08
HAART Containing Tenofovir (Viread) plus Emtricitabine (Emtriva) Is Effective for HIV-HBV Coinfected Patients, but Treatment Should Not Be Interrupted - 1/11/08
Antiretroviral Therapy Improves Poor Prognosis among HIV-HCV and HIV-HBV Coinfected Patients with Liver Cirrhosis - 12/14/07
Studies Look at Triple or Quadruple Infection with HBV, HCV, and HDV in HIV Positive Individuals - 12/11/07
Liver Enzyme Elevation and Immune Reconstitution in HIV Patients with and without Hepatitis B or C Coinfection - 12/07/07
HIV-HBV Coinfected Liver Transplant Recipients Have Outcomes Similar to Those of HIV Negative Patient
Hepatitis B Serological Markers May Change over Time in HIV-HBV Coinfected Individuals on Antiretroviral Therapy - 10/19/07
Mutations Associated with Lamivudine (3TC; Epivir) Resistance in Previously Untreated Hepatitis B Patients with and without HIV - 10/12/07
Good Response to Hepatitis B Treatment Is Associated Sustained Response to Antiretroviral Therapy in HIV-HBV Coinfected Patients   - 9/25/07
Bristol-Myers Squibb Warns Providers about Anti-HIV Activity of Entecavir (Baraclude) in HIV-HBV Coinfected Patients   - 8/21/07
Presence of Mixed Hepatitis B Genotypes Occurs More Frequently in HIV-HBV Coinfected Patients   - 8/17/07
Liver Disease and Survival Outcomes in HIV-HBV Coinfected Individuals   - 8/17/07
Safety of Atazanavir (Reyataz) in HIV-HBV and HIV-HCV Coinfected Patients with Pre-existing Liver Disease   - 8/10/07
Hepatitis B Virus and HIV Coinfection: Results of a Survey on Treatment Practices and Recommendations for Therapy   - 8/10/07
HIV Positive Individuals More Likely to Respond to High-dose HBV Vaccine  - 8/03/07
Complete HBV Genome Analysis in HIV Coinfected Individuals Identifies a Novel Core/precore Mutant   - 8/03/07
HAART Regimens Containing Tenofovir (Viread) or Lamivudine (Epivir) in HIV-HBV Coinfected Patients   - 7/31/07
Impact of Antiretroviral Treatment Interruption among HIV-HCV and HIV-HBV Coinfected Patients in the SMART Trial   - 7/31/07
Liver Toxicity Among HIV Positive African Patients on HAART is Associated with Tuberculosis Therapy and Hepatitis B Coinfection    - 7/07/07
Epidemiology, Diagnosis, and Treatment of Chronic Hepatitis B in HIV Positive Patients    - 7/03/07
Experimental HBV Drug Clevudine Shows Promise at the XVI International HIV Drug Resistance Workshop in Barbados   - 6/19/07
When HIV and Liver Disease Co-exist    - 6/12/07
Hepatitis Delta Infection May Worsen Disease Progression in HIV-HBV Coinfected Individuals    - 5/25/07
Revised Treatment Guidelines for Use of Entecavir in HIV-HBV Coinfected Patients  - 5/11/07
HAART Regimens Containing Tenofovir Plus Lamivudine or Emtricitabine Work Best for HIV-HBV Coinfected Patients  - 5/01/07
Role of HIV Coinfection in Mortality Related to Hepatitis B or C  - 4/24/07
Do HIV Care Providers Appropriately Manage Hepatitis B in Coinfected Patients?  - 4/10/07
HBV Less Likely than HCV to Cause Liver Disease Progression and Death in People with HIV  - 4/06/07
Treatment of Chronic Hepatitis B or C in HIV Positive Patients with Triple Infection - 4/3/07
Emergence of Tenofovir-resistant Mutations Is Uncommon in HIV-HBV Coinfected Patients - 4/3/07
Hepatitis B Virus Kinetics and Treatment Response in HIV-HBV Coinfected Patients  - 3/30/07
Long-term Lamivudine plus Tenofovir Is Safe and Effective in HIV-HBV Coinfected Patients  - 3/27/07
HBV Vaccination in HIV Positive People   3/20/07
Outcomes in HIV-HBV Coinfected Patients Treated with Drugs Active Against Both Viruses 10/17/06
Safety of Atazanavir in Patients with HIV/HCV or HIV/HBV Coinfection   9/12/06

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reports on Most Recent
HIV- and Hepatitis-related Research Conferences

AASLD 2007 - November 2008 
DDW 2008 - May 2008 
EASL 2008 - April 2008 
CROI 2008 - February 2008 

IAS 2007 - July 2007 


FDA-approved Hepatitis B
Treatments

Baraclude  (entecavir)
Epivir-HBV
   (lamivudine; 3TC)
Intron A   (interferon alfa-2b)

Hepsera  
(adefovir dipivoxil)
Pegasys  
(peginterferon alfa-2a)
Tyzeka   
(telbivudine)

FDA-approved HIV and
AIDS Treatments

Protease Inhibitors PIs
non Nucleoside Reverse
  
Transcriptase Inhibitors nNRTIs
Nucleoside / Nucleotide Reverse
  
Transcriptase Inhibitors NRTIs

Fixed-dose Combinations

Entry / Fusion Inhibitors EIs
Integrase Inhibitors

-
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
-Guidelines for Treatment of HIV-related OIs
-
Experimental Treatments


Website Sponsors